|
Fuster, JL; Cabanas, V; Blanquer, M; Sanchez-Salinas, A; Monserrat-Coll, J; Pascual-Gaquez, JF; Galera, A; Llinares, E; Bermudez-Cortes, M; Moraleda, JM. THE RECENT SINGLE CENTRE EXPERIENCE WITH PEDIATRIC SOLID TUMORS OF A NEW STEM CELL TRANSPLANTATION AND CELL THERAPY UNIT. BONE MARROW TRANSPLANTATION. 2014; 49:S366-S366.
AÑO: 2014; IF: 5.174
|
|
Melero, A; Blanquer, M; Sanchez-Salinas, A; Moraleda, JM; Monserrat, J; Majado, MJ; Cabanas-Perianes, V. AVASCULAR NECROSIS AFTER ALLOGENEIC TRANSPLANTATION HEMATOPOIETIC PROGENITORS: SINGLE-CENTER EXPERIENCE. BONE MARROW TRANSPLANTATION. 2014; 49:S275-S275.
AÑO: 2014; IF: 5.174
|
|
Fuster-Soler, JL; Monserrat-Coll, J; Campillo-Marauina, JA; Blanquer-Blanguer, M; Minguela-Puras, A; Sanchez-Salinas, A; Fita, A; Pascual-Gazquez, JF; Galera-Minarro, A; Llinares-Riestra, ME; Bermudez-Cortes, M; Moraleda, JM. T-cell depleted haploidentical stem cell transplantation for systemic relapse of aggressive pediatric solid tumors. BONE MARROW TRANSPLANTATION. 2015; 50:5602-5602.
AÑO: 2015; IF: 5.174
|
|
Cava, C; Blanquer, M; Garcia-Hernandez, AM; Majado, MJ; Menchon, P; Marin, A; Monserrat, J; Sanchez-Salinas, A; Moraleda, JM. Automated DMSO removal for cryopreserved peripheral blood hematopoietic progenitors with Sepax. Comparison of two different washing solutions. BONE MARROW TRANSPLANTATION. 2015; 50:S50-S50.
AÑO: 2015; IF: 5.174
|
|
Oliver-Caldes A, Espanol-Rego M, Zabaleta A, Gonzalez-Calle V, Navarro-Velazquez S, Inoges S, de Cerio AL, Cabanas V, Lopez-Munoz N, Rodriguez-Otero P, Reguera JL, Moreno DF, Martinez-Cibrian N, Lopez-Corral L, Perez-Amill L, Martin-Antonio B, Rosinol L, Cid J, Tovar N, Saez-Penataro J, Lopez-Parra M, Olesti E, Guillen E, Varea S, Rodriguez-Lobato LG, Battram AM, Gonzalez MS, Sanchez-Salinas A, Gonzalez-Navarro A, Ortiz-Maldonado V, Delgado J, Prosper F, Juan M, Martinez-Lopez J, Moraleda JM, Mateos MV, Urbano-Ispizua A, Paiva B, Pascal M, Fernandez de Larrea C. Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma. Clin Cancer Res. 2024 May 15;30(10):2085-2096. doi: 10.1158/1078-0432.CCR-23-3759. PubMed PMID: 38466644.
AÑO: 2024; IF: 10.0
|